Lhc Group Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2022 to a ratio of 6.08, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Lhc Group Inc in Dec 31 2022 quarter, has decreased to 60 days, compared to 61 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 376 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2022 from 2674 to 2876.

What is Receivable Turnover Ratio?
What is Lhc Group Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LHCG Receivables Turnover Ratio	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Receivable Change	-9.62 %	4.2 %	6.16 %	13.6 %	16.08 %
Y / Y Revenue Change	-4.33 %	2.03 %	5.55 %	8.89 %	9.6 %
Receivable Turnover Ratio (TTM)	6.08	6.01	6.04	6.04	6.12
LHCG's Total Ranking	# 2876	# 2674	# 803	# 2159	# 1564
Accounts Receivable average collection period days	60	61	60	60	60
Seq. Receivable Change	-13.21 %	6.18 %	-7.57 %	6.12 %	0.05 %
Seq. Revenue Change	-3.25 %	0.12 %	0.82 %	-2.05 %	3.18 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 38
Healthcare Sector	# 377
Overall Market	# 2876

Receivable Turnover Ratio Statistics
High	Average	Low
9.33	7.08	5.9
(Jun 30 2013)		(Dec 31 2020)

LHCG Company Profile • Back to LHCG Efficiency Comparisons • Compare LHCG Receivables Turnover Ratio to its Competitors

Financial Statements
Lhc Group Inc 's Accounts Receivable	$ 340 Millions	Visit LHCG's Balance sheet
Lhc Group Inc 's Sales TTM	$ 2,283 Millions	Visit LHCG's Income Statement
Sources of LHCG's Revenues		Visit LHCG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LHCG's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LHCG's Growth Rates	LHCG's Roa	LHCG's Inventory Turnover Ratio	LHCG's Dividend Comparisons
LHCG's Profitability Ratios	LHCG's Roi	LHCG's Asset Turnover Ratio	LHCG's Dividend Growth
LHCG's Valuation Ratios	LHCG's Roe	LHCG's Financial Strength Ratios	LHCG's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2022	Receivable at quarter ending Dec 31 2022
Emmaus Life Sciences Inc	18.21	$ 18.390 Millions	$ 1.010 Millions
Silence Therapeutics Plc	18.18	$ 17.501 Millions	$ 0.963 Millions
Biomerica Inc	17.68	$ 16.082 Millions	$ 0.910 Millions
Scisparc Ltd	17.49	$ 1.347 Millions	$ 0.077 Millions
Anika Therapeutics Inc	17.38	$ 156.236 Millions	$ 8.990 Millions
Eton Pharmaceuticals Inc	17.07	$ 21.251 Millions	$ 1.245 Millions
Solana Company	16.99	$ 0.926 Millions	$ 0.055 Millions
Intellia Therapeutics Inc	16.75	$ 52.121 Millions	$ 3.112 Millions
Chemed Corporation	16.58	$ 2,134.963 Millions	$ 128.736 Millions
Voyager Therapeutics Inc	16.36	$ 40.907 Millions	$ 2.500 Millions
U s Stem Cell Inc	16.32	$ 0.082 Millions	$ 0.005 Millions
Hcw Biologics Inc	16.07	$ 6.722 Millions	$ 0.418 Millions
Revance Therapeutics Inc	16.00	$ 132.565 Millions	$ 8.283 Millions
Qhslab Inc	15.84	$ 1.243 Millions	$ 0.078 Millions
Strata Critical Medical Inc	15.45	$ 146.120 Millions	$ 9.460 Millions
Ethema Health Corporation	15.39	$ 4.821 Millions	$ 0.313 Millions
Affimed N v	15.10	$ 43.563 Millions	$ 2.885 Millions
Patterson Companies Inc	15.08	$ 6,389.091 Millions	$ 423.718 Millions
Talkspace Inc	15.04	$ 119.567 Millions	$ 7.952 Millions
Valneva Se	14.88	$ 380.608 Millions	$ 25.581 Millions
Kiniksa Pharmaceuticals International Plc	14.42	$ 220.180 Millions	$ 15.267 Millions
Theralink Technologies Inc	14.36	$ 0.544 Millions	$ 0.038 Millions
23andme Holding Co	14.31	$ 307.671 Millions	$ 21.498 Millions
Travere Therapeutics Inc	13.98	$ 212.018 Millions	$ 15.170 Millions
Corcept Therapeutics Inc	13.88	$ 401.858 Millions	$ 28.953 Millions
Harrow Inc	13.77	$ 88.595 Millions	$ 6.436 Millions
Escalon Medical Corp	13.45	$ 10.938 Millions	$ 0.813 Millions
Cano Health Inc	13.22	$ 2,738.916 Millions	$ 207.142 Millions
Rayont Inc	13.20	$ 4.266 Millions	$ 0.323 Millions
Neurometrix Inc	12.80	$ 8.256 Millions	$ 0.645 Millions

Date modified: 2026-10-07T00:41:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.